BEXIMCO PHARMACEUTICALS LIMITED吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
26 0 公告 Delay in Results & Temporary Suspension BEXIMCO PHARMACE资讯 12-19 19:07
35 0 公告 Request of Extension to Publish Q1 Results BEXIMCO PHARMACE资讯 11-14 00:05
26 0 公告 Change of Name to Beximco Pharmaceuticals PLC. BEXIMCO PHARMACE资讯 11-04 15:21
39 0 公告 Request of Extension to Publish Financial Results BEXIMCO PHARMACE资讯 10-27 23:56
28 0 公告 Affordable treatment option for cystic fibrosis BEXIMCO PHARMACE资讯 10-24 14:19
32 0 公告 Further update on BSEC Order BEXIMCO PHARMACE资讯 09-15 20:19
46 0 公告 Update on BSEC Order BEXIMCO PHARMACE资讯 05-21 22:21
36 0 公告 Request of Extension to Publish Q3 Results BEXIMCO PHARMACE资讯 04-28 14:14
41 0 公告 Response to media reports and update on BSEC order BEXIMCO PHARMACE资讯 03-21 23:56
29 0 公告 Update on BSEC order BEXIMCO PHARMACE资讯 03-06 15:18
51 0 公告 Payment of Cash Dividend BEXIMCO PHARMACE资讯 01-30 23:03
60 0 公告 Board Changes BEXIMCO PHARMACE资讯 01-29 15:19
63 0 公告 Half Year Results 2024-25 BEXIMCO PHARMACE资讯 01-29 15:17
45 0 公告 Board of Directors BEXIMCO PHARMACE资讯 01-14 19:27
70 0 公告 Annual General Meeting Statement BEXIMCO PHARMACE资讯 12-30 15:08
66 0 公告 AGM Notification BEXIMCO PHARMACE资讯 11-19 15:14
91 0 公告 Financial Results for the First Quarter BEXIMCO PHARMACE资讯 11-14 15:18
76 0 公告 Update on Interim Order Supreme Court decision BEXIMCO PHARMACE资讯 11-12 18:05
80 0 公告 Further re the Temporary Suspension of Trading BEXIMCO PHARMACE资讯 11-11 19:06
75 0 公告 Results for the year ended 30 June 2024 BEXIMCO PHARMACE资讯 11-07 15:47
67 0 公告 Notification of Preliminary Results and AGM BEXIMCO PHARMACE资讯 10-29 15:08
53 0 公告 Update on Writ Petition and Interim Order BEXIMCO PHARMACE资讯 10-28 22:38
75 0 公告 Update on Writ Petition and Interim Order BEXIMCO PHARMACE资讯 10-02 14:13
68 0 公告 Clarification on Writ Petition BEXIMCO PHARMACE资讯 09-30 14:49
61 0 公告 Update regarding Vice-Chairman, Salman Rahman BEXIMCO PHARMACE资讯 09-06 21:20
65 0 公告 Correction and Clarification of Press Commentary BEXIMCO PHARMACE资讯 09-03 20:50
70 0 公告 Statement regarding Vice-Chairman, Salman Rahman BEXIMCO PHARMACE资讯 08-15 15:12
68 0 公告 Statement on political and business situation BEXIMCO PHARMACE资讯 08-13 15:08
67 0 公告 Q3 Financial Results BEXIMCO PHARMACE资讯 04-30 15:07
73 0 公告 Appointment of Managing Director BEXIMCO PHARMACE资讯 03-04 16:09
68 0 公告 Half Year Results 2023-24 BEXIMCO PHARMACE资讯 01-30 16:23
133 0 公告 Payment of Cash Dividend BEXIMCO PHARMACE资讯 01-25 00:00
66 0 公告 Board Change BEXIMCO PHARMACE资讯 01-11 20:53
98 0 公告 AGM Statement BEXIMCO PHARMACE资讯 12-28 18:48
83 0 公告 Notice of AGM BEXIMCO PHARMACE资讯 11-06 21:22
72 0 公告 Financial Results for the First Quarter BEXIMCO PHARMACE资讯 11-06 16:10
77 0 公告 Results for the year ended 30 June 2023 BEXIMCO PHARMACE资讯 11-01 16:10
89 0 公告 Notification of Preliminary Results and AGM BEXIMCO PHARMACE资讯 10-20 15:11
77 0 公告 Clarification on Press Report BEXIMCO PHARMACE资讯 09-11 18:20
86 0 公告 Re-appointment of Independent Director BEXIMCO PHARMACE资讯 08-31 23:58
147 0 公告 Q3 Financial Results BEXIMCO PHARMACE资讯 05-02 15:03
115 0 公告 Holdings in Company BEXIMCO PHARMACE资讯 04-12 00:04
162 0 公告 Holdings in Company BEXIMCO PHARMACE资讯 03-31 19:19
156 0 公告 Half Year Results 2022-23 BEXIMCO PHARMACE资讯 01-30 16:19
149 0 公告 Payment of Cash Dividend BEXIMCO PHARMACE资讯 01-19 16:18
137 0 公告 Annual General Meeting Statement BEXIMCO PHARMACE资讯 12-23 16:19
124 0 公告 Second Price Monitoring Extn BEXIMCO PHARMACE资讯 11-29 23:26
139 0 公告 Price Monitoring Extension BEXIMCO PHARMACE资讯 11-29 23:06
112 0 公告 AGM Notification BEXIMCO PHARMACE资讯 11-16 16:40
98 0 公告 Financial Results for the First Quarter BEXIMCO PHARMACE资讯 11-11 16:02
158 0 公告 Results for the 12-month period ended 30 June 2022 BEXIMCO PHARMACE资讯 11-08 16:05
158 0 公告 Notification of Preliminary Results and AGM BEXIMCO PHARMACE资讯 10-28 15:11
139 0 公告 Q3 Financial Results BEXIMCO PHARMACE资讯 04-28 14:15
197 0 公告 Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC BEXIMCO PHARMACE资讯 04-01 14:22
195 0 公告 MPP sub-license for Pfizer’s COVID-19 treatment BEXIMCO PHARMACE资讯 03-17 22:54
179 0 公告 Half Year Results 2021-22 BEXIMCO PHARMACE资讯 01-28 15:10
248 0 公告 Payment of Cash Dividend BEXIMCO PHARMACE资讯 01-21 15:26
794 0 公告 License to produce molnupiravir for COVID-19 BEXIMCO PHARMACE资讯 01-20 17:13
153 0 公告 World's first generic version of Pfizer’s Paxlovi BEXIMCO PHARMACE资讯 12-30 18:44
117 0 公告 Annual General Meeting Statement BEXIMCO PHARMACE资讯 12-24 15:32
2355 0 公告 Delivery of COVID-19 vaccine doses BEXIMCO PHARMACE资讯 12-08 15:22
1136 0 公告 Update on the supply of COVID-19 vaccine BEXIMCO PHARMACE资讯 12-02 15:13
169 0 公告 Statement re: media comment BEXIMCO PHARMACE资讯 11-24 15:54
121 0 公告 Notice of AGM BEXIMCO PHARMACE资讯 11-16 15:13
155 0 公告 Results for First Quarter Ended 30 September 2021 BEXIMCO PHARMACE资讯 11-11 19:30
143 0 公告 Launch of world’s first generic molnupiravir BEXIMCO PHARMACE资讯 11-09 15:20
228 0 公告 Results for the year ended 30 June 2021 BEXIMCO PHARMACE资讯 11-02 15:16
150 0 公告 Notification of Preliminary Results and AGM BEXIMCO PHARMACE资讯 10-21 19:49
2651 0 公告 Update on the supply of COVID-19 vaccine BEXIMCO PHARMACE资讯 10-11 14:12
260 0 公告 Completion of Sanofi Bangladesh Acquisition BEXIMCO PHARMACE资讯 10-01 14:13
144 0 公告 Sanofi Bangladesh Share Purchase Agreement signed BEXIMCO PHARMACE资讯 09-14 19:43
310 0 公告 Acquisition Approved by Bangladesh Bank BEXIMCO PHARMACE资讯 09-03 00:00
259 0 公告 Statement re: media comment BEXIMCO PHARMACE资讯 08-26 01:08
325 0 公告 FDA approval for muscle relaxant drug Baclofen BEXIMCO PHARMACE资讯 07-26 14:36
824 0 公告 Update on the supply of COVID-19 vaccine BEXIMCO PHARMACE资讯 07-07 21:34
338 0 公告 Q3 Financial Results BEXIMCO PHARMACE资讯 04-30 14:17
306 0 公告 Update on the supply of COVID-19 vaccine BEXIMCO PHARMACE资讯 04-28 14:22
231 0 公告 Second Price Monitoring Extn BEXIMCO PHARMACE资讯 03-25 00:59
231 0 公告 Price Monitoring Extension BEXIMCO PHARMACE资讯 03-25 00:56
304 0 公告 Second Price Monitoring Extn BEXIMCO PHARMACE资讯 03-24 22:15
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500